|
1
|
Marenholz I, Heizmann CW and Fritz G: S100
proteins in mouse and man: From evolution to function and pathology
(including an update of thenomenclature). Biochem Biophys Res
Commun. 322:1111–1122. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Heizmann CW, Fritz G and Schäfer BW: S100
proteins: Structure, functions and pathology. Front Biosci.
7:d1356–d1368. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ragin CC, Modugno F and Gollin SM: The
epidemiology and risk factors of head and neck cancer: A focus on
human papillomavirus. J Dent Res. 86:104–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zha C, Jiang XH and Peng SF: iTRAQ-based
quantitative proteomic analysis on S100 calcium binding protein A2
in metastasis of laryngeal cancer. PLoS One. 10:e01223222015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moriyama-Kita M, Endo Y, Yonemura Y,
Heizmann CW, Schäfer BW, Sasaki T and Yamamoto E: Correlation of
S100A4 expression with invasion and metastasis in oral squamous
cell carcinoma. Oral Oncol. 40:496–500. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nakashima T, Yano G, Hayashi I and Katsuta
Y: Epithelial membrane antigen and S-100 protein-labeled cells in
primary and metastatic laryngeal carcinomas. Head Neck. 14:445–451.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang C, Zhang Z, Li L, Zhang J, Wang J,
Fan J, Jiao B and Zhao S: S100A11 is a migration-related protein in
laryngeal squamous cell carcinoma. Int J Med Sci. 10:1552–1559.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Moriyama-Kita M, Endo Y, Yonemura Y,
Heizmann CW, Schäfer BW, Sasaki T and Yamamoto E: Correlation of
S100A4 expression with invasion and metastasis in oral squamous
cell carcinoma. Oral Oncol. 401:496–500. 2004. View Article : Google Scholar
|
|
9
|
Sung FL, Poon TC, Hui EP, Ma BB, Liong E,
To KF, Huang DP and Chan AT: Antitumor effect and enhancement of
cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma
cells. In Vivo. 19:237–245. 2005.PubMed/NCBI
|
|
10
|
Paiar F, Di Cataldo V, Zei G, Pasquetti
EM, Cecchini S, Meattini I, Mangoni M, Agresti B, Iermano C, Bonomo
P and Biti G: Role of chemotherapy in nasopharyngeal carcinoma.
Oncol Rev. 6:e12012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu H, Peng L, Yuan X, Hao Y, Lu Z, Chen J,
Cheng J, Deng S, Gu J, Pang Q and Qin J: Concurrent
chemoradiotherapy in locally advanced nasopharyngeal carcinoma: A
treatment paradigm also applicable to patients in Southeast Asia.
Cancer Treat Rev. 35:345–353. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Baujat B, Audry H, Bourhis J, Chan AT,
Onat H, Chua DT, Kwong DL, Al-Sarraf M, Chi KH, Hareyama M, et al:
Chemotherapy in locally advanced nasopharyngeal carcinoma: An
individual patient data meta-analysis of eight randomized trials
and 1,753 patients. Int J Radiat Oncol Biol Phys. 64:47–56. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Becker T, Gerke V, Kube E and Weber K:
S100P, a novel Ca(2+)-binding protein from human placenta. cDNA
cloning, recombinant protein expression and Ca2+ binding
properties. Eur J Biochem. 207:541–547. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Da Silva ID Guerreiro, Hu YF, Russo IH, Ao
X, Salicioni AM, Yang X and Russo J: S100P calcium-binding protein
overexpression is associated with immortalization of human breast
epithelial cells in vitro and early stages of breast cancer
development in vivo. Int J Oncol. 16:231–240. 2000.PubMed/NCBI
|
|
15
|
Beer DG, Kardia SL, Huang CC, Giordano TJ,
Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, et al:
Gene-expression profiles predict survival of patients with lung
adenocarcinoma. Nat Med. 8:816–824. 2002.PubMed/NCBI
|
|
16
|
Shyu RY, Huang SL and Jiang SY: Retinoic
acid increases expression of the calcium-binding protein S100P in
human gastric cancer cells. J Biomed Sci. 10:313–319. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Basu GD, Azorsa DO, Kiefer JA, Rojas AM,
Tuzmen S, Barrett MT, Trent JM, Kallioniemi O and Mousses S:
Functional evidence implicating S100P in prostate cancer
progression. Int J Cancer. 123:330–339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW,
Tsang YS, Wong N, Whitney BM and Lee JC: Nasopharyngeal carcinoma
cell line (C666-1) consistently harbouring Epstein-Barr virus. Int
J Cancer. 83:121–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Arumugam T, Simeone DM, Van Golen K and
Logsdon CD: S100P promotes pancreatic cancer growth, survival, and
invasion. Clin Cancer Res. 11:5356–5364. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wobus M, Rangwala R, Sheyn I, Hennigan R,
Coila B, Lower EE, Yassin RS and Sherman LS: CD44 associates with
EGFR and erbB2 in metastasizing mammary carcinoma cells. Appl
Immunohistochem Mol Morphol. 10:34–39. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun Y, Liu M, Yang B, Li B and Lu J: Role
of siRNA silencing of MMP-2 gene on invasion and growth of
laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol.
265:1385–1391. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen X, Qiu J, Yang D, Lu J, Yan C, Zha X
and Yin Y: MDM2 promotes invasion and metastasis in invasive ductal
breast carcinoma by inducing matrix metalloproteinase-9. PLoS One.
8:e787942013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao H, Zhang X, Zheng Y, Peng L, Hou J and
Meng H: S100A9-induced release of interleukin (IL)-6 and IL-8
through toll-like receptor 4 (TLR4) in human periodontal ligament
cells. Mol Immunol. 67:223–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen B, Miller AL, Rebelatto M, Brewah Y,
Rowe DC, Clarke L, Czapiga M, Rosenthal K, Imamichi T, Chen Y, et
al: S100A9 induced inflammatory responses are mediated by distinct
damage associated molecular patterns (DAMP) receptors in vitro and
in vivo. PLoS One. 10:e01158282015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leclerc E, Fritz G, Vetter SW and Heizmann
CW: Binding of S100 proteins to RAGE: An update. Biochim Biophys
Acta. 1793:993–1007. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Parkkila S, Pan PW, Ward A, Gibadulinova
A, Oveckova I, Pastorekova S, Pastorek J, Martinez AR, Helin HO and
Isola J: The calcium-binding protein S100P in normal and malignant
human tissues. BMC Clin Pathol. 8:22008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang L, Lai YK, Zhang J, Wang H, Lin MC,
He ML and Kung HF: Targeting S100P inhibits colon cancer growth and
metastasis by Lentivirus-mediated RNA interference and proteomic
analysis. Mol Med. 17:709–716. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dykxhoorn DM and Lieberman J: Knocking
down disease with siRNAs. Cell. 126:231–235. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sy SM, Wong N, Lee TW, Tse G, Mok TS, Fan
B, Pang E, Johnson PJ and Yim A: Distinct patterns of genetic
alterations in adenocarcinoma and squamous cell carcinoma of the
lung. Eur J Cancer. 40:1082–1094. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bravo-Cordero JJ, Hodgson L and Condeelis
J: Directed cell invasion and migration during metastasis. Curr
Opin Cell Biol. 24:277–283. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R,
Hammond EH, Fu KK and Milas L: Impact of epidermal growth factor
receptor expression on survival and pattern of relapse in patients
with advanced head and neck carcinoma. Cancer Res. 62:7350–7356.
2002.PubMed/NCBI
|
|
33
|
Wobus M, Rangwala R, Sheyn I, Hennigan R,
Coila B, Lower EE, Yassin RS and Sherman LS: CD44 associates with
EGFR and erbB2 in metastasizing mammary carcinoma cells. Appl
Immunohistochem Mol Morphol. 10:34–39. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kivisaari AK, Kallajoki M, Ala-aho R,
McGrath JA, Bauer JW, Königová R, Medvecz M, Beckert W, Grénman R
and Kähäri VM: Matrix metalloproteinase-7 activates heparin-binding
epidermal growth factor-like growth factor in cutaneous squamous
cell carcinoma. Br J Dermatol. 163:726–735. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Neeper M, Schmidt AM, Brett J, Yan SD,
Wang F, Pan YC, Elliston K, Stern D and Shaw A: Cloning and
expression of a cell surface receptor for advanced glycosylation
end products of proteins. J Biol Chem. 267:14998–15004.
1992.PubMed/NCBI
|
|
37
|
Barclay AN: Membrane proteins with
immunoglobulin-like domains-a master superfamily of interaction
molecules. Semin Immunol. 15:215–223. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schmidt AM, Yan SD, Yan SF and Stern DM:
The biology of the receptor for advanced glycation end products and
its ligands. Biochim Biophys Acta. 1498:99–111. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Arumugam T, Simeone DM, Schmidt AM and
Logsdon CD: S100P stimulates cell proliferation and survival via
receptor for activated glycation end products (RAGE). J Biol Chem.
279:5059–5065. 2004. View Article : Google Scholar : PubMed/NCBI
|
